{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T09:26:15Z","timestamp":1793179575025,"version":"4.5.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1586,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T00:00:00Z","timestamp":1629158400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We aimed to detail the early clinical experience with pVAD 5.5 at a large academic medical centre. Impella\u00ae 5.5 (Abiomed) is a temporary peripherally inserted left ventricular assist device (pVAD) used for the treatment of cardiogenic shock (CS). This system has several modifications aimed at improving deliverability and durability over the pVAD 5.0 system, but real-world experience with this device remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We collected clinical and outcome data on all patients supported with pVAD 5.5 at our centre between February and December 2020, including procedural and device-related complications. Fourteen patients with pVAD 5.5 were included. Aetiology of CS was acute myocardial infarction (n = 6), decompensated heart failure (n = 6), suspected myocarditis (n = 1), and post-cardiotomy CS (n = 1). Four patients received pVAD 5.5 after being on inotropes alone, two were escalated from intra-aortic balloon pump, two were escalated from pVAD CP, and six patients were transitioned to pVAD 5.5 from extracorporeal membrane oxygenation. Median duration of pVAD 5.5 support was 12 (interquartile range 7, 25) days. Complications included axillary insertion site haematoma (n = 3), acute kidney injury (n = 3), severe thrombocytopenia (n = 1), and stroke (n = 1). No valve injury or limb complications occurred. Survival to device explant for recovery or transition to another therapy was 11\/14 (79%) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this early experience of the pVAD 5.5, procedural and device-related complications were observed but were manageable, and overall survival was high in this critically ill cohort, particularly when the device was used as a bridge to other therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13512","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T04:52:17Z","timestamp":1629175937000},"page":"3720-3725","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["A Case Series Analysis on the Clinical Experience of Impella 5.5\u00ae at a Large Tertiary Care Centre"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7347-1298","authenticated-orcid":false,"given":"Peter J.","family":"Kennel","sequence":"first","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital , 161 Fort Washington Avenue, New York, NY, 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Lumish","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital , 161 Fort Washington Avenue, New York, NY, 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Kaku","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, NewYork-Presbyterian Hospital , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Fried","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital , 161 Fort Washington Avenue, New York, NY, 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay J.","family":"Kirtane","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital , 161 Fort Washington Avenue, New York, NY, 10032 ,","place":["USA"]},{"name":"Division of Cardiology, Cardiovascular Research Foundation , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Karmpaliotis","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital , 161 Fort Washington Avenue, New York, NY, 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroo","family":"Takayama","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, NewYork-Presbyterian Hospital , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Naka","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, NewYork-Presbyterian Hospital , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sayer","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital , 161 Fort Washington Avenue, New York, NY, 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Uriel","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital , 161 Fort Washington Avenue, New York, NY, 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Takeda","sequence":"additional","affiliation":[{"name":"Division of Cardiothoracic Surgery, NewYork-Presbyterian Hospital , New York, NY ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Masoumi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Columbia University Irving Medical Center\/NewYork-Presbyterian Hospital , 161 Fort Washington Avenue, New York, NY, 10032 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,17]]},"reference":[{"key":"2026012114221737100_ehf213512-bib-0001","author":"First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump|ABIOMED, Inc"},{"key":"2026012114221737100_ehf213512-bib-0002","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/MAT.0000000000001194","article-title":"New surgical circulatory support system outcomes","volume":"66","author":"Ramzy","year":"2020","journal-title":"ASAIO J"},{"key":"2026012114221737100_ehf213512-bib-0003","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/MAT.0000000000001283","article-title":"Impella 5.5 versus Centrimag: a head-to-head comparison of device hemocompatibility","volume":"66","author":"Roka-Moiia","year":"2020","journal-title":"ASAIO J"},{"key":"2026012114221737100_ehf213512-bib-0004","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcrc.2019.11.007","article-title":"Switching to Impella 5.0 decreases need for transfusion in patients undergoing temporary mechanical circulatory support","volume":"57","author":"Castro","year":"2020","journal-title":"J Crit Care"},{"key":"2026012114221737100_ehf213512-bib-0005","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1093\/ejcts\/ezs533","article-title":"Valve Academic Research Consortium (VARC)-2. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)","volume":"42","author":"Kappetein","year":"2012","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026012114221737100_ehf213512-bib-0006","volume-title":"KDIGO Clinical practice guideline for acute kidney injury"},{"key":"2026012114221737100_ehf213512-bib-0007","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2026012114221737100_ehf213512-bib-0008","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jcrc.2019.12.028","article-title":"Bridging INTERMACS 1 patients from VA-ECMO to LVAD via Impella 5.0: de-escalate and ambulate","volume":"57","author":"Bertoldi","year":"2020","journal-title":"J Crit Care"},{"key":"2026012114221737100_ehf213512-bib-0009","doi-asserted-by":"crossref","first-page":"835","DOI":"10.21037\/atm.2020.03.152","article-title":"Complications associated with mechanical circulatory support","volume":"8","author":"Ali","year":"2020","journal-title":"Ann Transl Med"},{"key":"2026012114221737100_ehf213512-bib-0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40119-019-00152-8","article-title":"Complications of temporary percutaneous mechanical circulatory support for cardiogenic shock: an appraisal of contemporary literature","volume":"8","author":"Subramaniam","year":"2019","journal-title":"Cardiol Ther"},{"key":"2026012114221737100_ehf213512-bib-0011","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijcard.2020.09.044","article-title":"Short term outcomes of Impella in cardiogenic shock: a review and meta-analysis of observational studies","volume":"324","author":"Iannaccone","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026012114221737100_ehf213512-bib-0012","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1111\/jocs.15038","article-title":"Comparison of device-specific adverse event profiles between Impella platforms","volume":"35","author":"Chen","year":"2020","journal-title":"J Card Surg"},{"key":"2026012114221737100_ehf213512-bib-0013","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/icvts\/ivaa150","article-title":"Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device","volume":"31","author":"Nersesian","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"2026012114221737100_ehf213512-bib-0014","author":"ABIOMED|Important Safety Information"},{"key":"2026012114221737100_ehf213512-bib-0015","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.carrev.2019.05.001","article-title":"Prevalence and clinical correlates of extended mechanical support in patients undergoing high-risk percutaneous coronary intervention in current clinical practice: insights from the cVAD registry","volume":"21","author":"Davila","year":"2020","journal-title":"Cardiovasc Revasc Med"},{"key":"2026012114221737100_ehf213512-bib-0016","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13818","article-title":"Direct bridging to cardiac transplantation with the surgically implanted Impella 5.0 device","volume":"34","author":"Seese","year":"2020","journal-title":"Clin Transplant"},{"key":"2026012114221737100_ehf213512-bib-0017","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.athoracsur.2019.08.041","article-title":"A new paradigm in mechanical circulatory support: 100-patient experience","volume":"109","author":"Chung","year":"2020","journal-title":"Ann Thorac Surg"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13512","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13512","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/5\/3720\/65566089\/eschf_8_5_3720.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/5\/3720\/65566089\/eschf_8_5_3720.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:27:42Z","timestamp":1769023662000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/5\/3720\/8345825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,17]]},"references-count":17,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,8,17]]},"published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13512","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10]]},"published":{"date-parts":[[2021,8,17]]},"assertion":[{"value":"2021-05-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-04","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}